AAPL 207.19 -0.19 (-0.09%)MSFT 129.17 +4.11 (+3.29%)FB 193.85 +2.77 (+1.45%)ZNGA 5.58 0 (+0.09%)NVDA 191.18 -0.12 (-0.06%)WBA 53.48 -0.04 (-0.07%)GOOG 1256.05 -0.4 (-0.03%)PIH 5.25 -0.05 (-0.94%)
AAPL 207.19 -0.19 (-0.09%)MSFT 129.17 +4.11 (+3.29%)FB 193.85 +2.77 (+1.45%)ZNGA 5.58 0 (+0.09%)NVDA 191.18 -0.12 (-0.06%)WBA 53.48 -0.04 (-0.07%)GOOG 1256.05 -0.4 (-0.03%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ADMA Quote ADMA Biolog

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 10 43 23
ShortTermInvest 5 0 0
Cash 15 43 23
AccountReceivab 1 4 1
Inventories 5 13 19
DeferredIncomeT 0 0 0
OtherCurrentAss 0 2 0
TotalCurrentAss 22 63 45
PPE 4 32 34
AccumulatedDepr -2 -1 -3
NetPPE 2 30 30
EquityAndOtherI 0 0 0
Goodwill 0 4 4
IntangibleAsset 0 5 4
OtherLTAssets 0 6 7
TotalNonCurrent 2 45 44
TotalAssets 24 108 89
ShortTermDebt 6 0 0
AccountsPayable 3 6 6
TaxesPayable 0 0 0
AccruedLiabilit 2 3 4
DeferredRevenue 0 0 0
OtherCurrentLia 0 0 0
TotalCurrentLia 11 9 10
Debt 14 43 44
DeferredTaxesLi 0 0 0
DeferredRevenue 3 3 2
OtherLTLiabilit 0 13 13
TotalNonCurrent 17 58 59
TotalLiabilitie 28 68 69
CommonStock 0 0 0
AdditionalPaidI 102 191 236
RetainedEarning -107 -151 -216
AccumulatedOthe 0 0 0
TotalStockholde -4 40 20
TotalLiabilitie 24 108 89
ADMA Biologics Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ADMA Biologics Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.